Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
5,410.00
+20.00 (0.37%)
Sep 11, 2026, 3:30 PM KST
| Market Cap | 129.34B +1.7% |
| Revenue (ttm) | 279.55B +14.8% |
| Net Income | 5.05B +1,117.6% |
| EPS | 210.97 +1,118.7% |
| Shares Out | 23.91M |
| PE Ratio | 25.64 |
| Forward PE | n/a |
| Dividend | 50.00 (0.92%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 15,788 |
| Open | 5,500.00 |
| Previous Close | 5,390.00 |
| Day's Range | 5,320.00 - 5,550.00 |
| 52-Week Range | 4,700.00 - 9,300.00 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |